TDOC - Teladoc Health, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
492,552
417,907
233,279
123,157
77,384
Cost of Revenue
160,506
128,735
61,623
31,971
21,041
Gross Profit
332,046
289,172
171,656
91,186
56,343
Operating Expenses
Research Development
59,773
54,373
34,459
21,815
14,210
Selling General and Administrative
306,192
263,045
176,913
113,648
93,055
Total Operating Expenses
406,831
355,135
233,854
146,891
112,128
Operating Income or Loss
-74,785
-65,963
-62,198
-55,705
-55,785
Interest Expense
-
26,112
-
-
-
Total Other Income/Expenses Net
-3,740
-4,891
-27,318
-15,413
0
Income Before Tax
-106,586
-96,966
-107,007
-73,706
-57,984
Income Tax Expense
1,031
118
-225
510
36
Income from Continuing Operations
-107,617
-97,084
-106,782
-74,216
-58,020
Net Income
-107,617
-97,084
-106,782
-74,216
-58,020
Net Income available to common shareholders
-107,617
-97,084
-106,782
-74,216
-58,020
Reported EPS
Basic
-
-1.47
-1.93
-1.75
-2.91
Diluted
-
-1.47
-1.93
-1.75
-2.91
Weighted average shares outstanding
Basic
-
65,845
55,427
42,331
19,917
Diluted
-
65,845
55,427
42,331
19,917
EBITDA
-
-30,361
-43,103
-47,435
-50,922